Sunzen Biotech Bhd Market Cap ($43.17 Million)
Market Cap & Net Worth: Sunzen Biotech Bhd (0148)
Sunzen Biotech Bhd market cap. Sunzen Biotech Bhd (KLSE:0148) has a market capitalization of $43.17 Million (RM171.96 Million) as of October 31, 2026. Listed on the KLSE stock exchange, this Malaysia-based company holds position #22258 globally and #504 in its home market, demonstrating a -2.22% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sunzen Biotech Bhd's stock price RM0.22 by its total outstanding shares 781638353 (781.64 Million).
Sunzen Biotech Bhd Market Cap History (2015–2026)
Sunzen Biotech Bhd market cap history from 2015 to 2026. Data shows change from $70.57 Million to $43.17 Million (-4.14% CAGR). Check 0148 live share price for real-time trading data and today's change.
Sunzen Biotech Bhd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sunzen Biotech Bhd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see 0148 operating cash flow for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.69x
Sunzen Biotech Bhd's market cap is 0.69 times its annual revenue
Latest Price to Earnings (P/E) Ratio
11.91x
Sunzen Biotech Bhd's market cap is 11.91 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $39.80 Million | $40.01 Million | -$130.07K | 0.99x | N/A |
| 2017 | $60.84 Million | $303.45 Million | $3.47 Million | 0.20x | 17.51x |
| 2018 | $32.38 Million | $296.16 Million | -$6.94 Million | 0.11x | N/A |
| 2019 | $20.61 Million | $240.58 Million | -$16.25 Million | 0.09x | N/A |
| 2020 | $35.32 Million | $82.23 Million | -$13.23 Million | 0.43x | N/A |
| 2021 | $49.06 Million | $90.48 Million | $680.14K | 0.54x | 72.13x |
| 2022 | $39.25 Million | $97.09 Million | $3.75 Million | 0.40x | 10.47x |
| 2023 | $58.87 Million | $85.82 Million | $4.94 Million | 0.69x | 11.91x |
Competitor Companies of 0148 by Market Capitalization
Companies near Sunzen Biotech Bhd in the global market cap rankings as of October 31, 2026. See Sunzen Biotech Bhd (0148) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to Sunzen Biotech Bhd by market ranking:
- Nestlé S.A (F:NESM): Ranked #88 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #102 globally with a market cap of $199.45 Billion USD ( CHF157.76 Billion CHF).
- Danone SA (PA:BN): Ranked #542 globally with a market cap of $49.33 Billion USD ( €42.19 Billion EUR).
- Danone SA (F:BSND): Ranked #674 globally with a market cap of $39.61 Billion USD ( €33.88 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Nestlé S.A | F:NESM | $224.33 Billion | €91.60 |
| #102 | Nestle S.A. | SW:NESN | $199.45 Billion | CHF84.70 |
| #542 | Danone SA | PA:BN | $49.33 Billion | €65.52 |
| #674 | Danone SA | F:BSND | $39.61 Billion | €12.40 |
Market Capitalization of Sunzen Biotech Bhd (2015–2026)
Market capitalization of Sunzen Biotech Bhd from 2015 to today. Between 2015 and today, Sunzen Biotech Bhd's market cap moved from $70.57 Million to $ 43.17 Million, with a yearly change of -4.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | RM43.17 Million | -16.98% |
| 2025 | RM52.00 Million | -18.46% |
| 2024 | RM63.78 Million | +8.33% |
| 2023 | RM58.87 Million | +50.00% |
| 2022 | RM39.25 Million | -20.00% |
| 2021 | RM49.06 Million | +38.89% |
| 2020 | RM35.32 Million | +71.43% |
| 2019 | RM20.61 Million | -36.36% |
| 2018 | RM32.38 Million | -46.77% |
| 2017 | RM60.84 Million | +52.86% |
| 2016 | RM39.80 Million | -43.60% |
| 2015 | RM70.57 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Sunzen Biotech Bhd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $43.17 Million USD |
| MoneyControl | $43.17 Million USD |
| MarketWatch | $43.17 Million USD |
| marketcap.company | $43.17 Million USD |
| Reuters | $43.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more